Colon Cancer Screening made Simple
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
Blog
Second Sight Develops A Second Chance for the Blind
An implant designed to restore a degree of sight to people with advanced retinal degenerative diseases has been approved for sale in the European Economic Area.
Breakthrough Study Indicates CNS Response’s Referenced-EEG Enables Physicians to Significantly Improve Success Rates in Treating Depression
According to The Journal of Psychiatric Research, a breakthrough study by CNS Response, Inc. (OTCBB: CNSO), reveals that physicians using CNS’s Referenced-EEG® (rEEG), an online reference database, were able to significantly improve their success in treating patients with depression, including patients with treatment-resistant depression.
Vicor Technologies Announces Exclusive Distribution Agreement for its PD2i® Products in Israel
David H. Fater, CEO of Vicor Technologies, Inc., today announced that the Company has entered into an agreement with Hadar Training and Medical Services
NimoGel™ Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study
Contrary to popular belief, New Jersey has many hidden treasures and now Edge Therapeutics, a Newark, New Jersey based biopharmaceutical company has made tremendous headway in their quest for a cure for debilitating and potentially fatal brain injuries.
NeoGenomics Reports Fourth Quarter and Full Year 2010 Results
FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ — NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.
Mobisante Wins FDA Approval For The World’s First smartphone-based ultrasound imaging system
Mobisante, Inc., a privately held medical device company located in Redmond, WA, announced recently that it has received 510(k) clearance from the FDA for its smartphone-based ultrasound imaging system, MobiUS.
Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products recently announced the appointment of Arthur L. Rosenthal to Chairman of its Board of Directors.
ADVENTRX Pharmaceuticals Provides Update on ANX-514
ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates principally for the treatment of cancer, recently provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.
T-Ray Science Announces Name Change
T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.